Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 313.20
-1.55 (-0.49%)
At close: Jan 19, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 31.04 billion as of January 23, 2026. Its market cap has decreased by -35.54% in one year.
Market Cap
31.04B
Enterprise Value
33.85B
Revenue
8.74B
Ranking
n/a
PE Ratio
54.54
Stock Price
313.20
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 31.04B, an increase of 8,592.06%. That is a compound annual growth rate of 19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 31.04B | -8.08% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 62.32B |
| Unichem Laboratories | 28.08B |
| Hikal | 25.63B |
| Shukra Pharmaceuticals | 21.15B |
| Morepen Laboratories | 19.50B |
| Novartis India | 19.27B |
| Amrutanjan Health Care | 17.64B |
| Bliss GVS Pharma | 16.61B |